"New Over Mu" FDA-Approved Non-Opioid Medications for the Management of Migraine

The Food and Drug Administration continually announces new single entity, combination and rebranded medications. The purpose of this presentation is to familiarize the participant with those non-opioid medications with an indication for the management of migraine that have gained FDA approval since 2018.

Learning Objectives

  • Review the most recent three years of FDA approved non-opioid medications for pain
  • Recall the mechanism of action for each of these agents
  • Describe safe and effective use of these agents in a given patient population
Course summary
Available credit: 
  • 1.00 AANP
  • 1.00 ACCME (All Other)
  • 1.00 ACCME (MD/DO Only)
  • 1.00 ACPE Pharmacy
  • 1.00 ANCC
  • 1.00 APA
Course opens: 
11/08/2023
Course expires: 
11/08/2024
Part of: 
Pharmacotherapy Track
Rating: 
0

Available Credit

  • 1.00 AANP
  • 1.00 ACCME (All Other)
  • 1.00 ACCME (MD/DO Only)
  • 1.00 ACPE Pharmacy
  • 1.00 ANCC
  • 1.00 APA
Please login or register to take this course.